Related Experiment Video
Updated: Feb 8, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol
Toshihiko Ikuta1, Kazumichi Fujioka1, Yumi Sato2
1Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Insights
Congenital complete atrioventricular block (CCAVB) in newborns can cause intractable bradycardia. A transdermal tulobuterol patch successfully treated bradycardia, offering a potential alternative to pacemakers.
Area of Science:
- Pediatric Cardiology
- Neonatology
- Pharmacology
Background:
- Congenital complete atrioventricular block (CCAVB) necessitates permanent pacemaker implantation.
- Postnatal medical therapy for bradycardia in CCAVB remains controversial.
Observation:
- A newborn presented with CCAVB and intractable bradycardia.
- The infant's condition did not respond to conventional treatments.
Findings:
- Transdermal tulobuterol, a selective β2-adrenoceptor agonist, was administered.
- Tulobuterol effectively managed the infant's bradycardia, demonstrating positive chronotropic effects.
Implications:
- Transdermal tulobuterol may serve as an optional medical therapy for CCAVB.
- This approach offers a potential alternative when pacemaker implantation is not feasible or immediately available.
Abstract:
Congenital complete atrioventricular block (CCAVB) is a condition in which the atria and ventricles beat independently of each other. CCAVB cases require permanent pacemaker implantation until adulthood. Nevertheless, consensus regarding postnatal medical therapy for bradycardia has not been reached. Here we report the case of a newborn with CCAVB, whose intractable bradycardia was successfully treated with transdermal tulobuterol. Tulobuterol is a selective β2-adrenoceptor agonist, widely used safely as bronchodilator in children. It also has positive inotropic and chronotropic effect via β1-adrenoceptors. We believe the tulobuterol patch can be used as an optional therapy for CCAVB where pacemaker implantation is not available.
Related Concept Videos
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Block Diagram Reduction
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
Elements of Block Diagrams
A block diagram typically includes essential elements such as comparators, blocks, and feedback loops. Each of these elements...
Relation between Mathematical Equations and Block Diagrams
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia

